Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Eric
Eric graduated from Oberlin College and Conservatory with a BA in Hispanic Studies and BM in Composition. He then received an MA in Teaching at Boston University, where he was awarded the Future Language Educator Scholarship.
Carla
Carla is an MD/PhD candidate in the Health Sciences and Technology program at Harvard-MIT. She earned her BS in Bioengineering from UPenn and her MS in Regenerative Medicine from the National University of Ireland.